New Compound Protects Against Neurodegeneration

In nematode worms the new compound that protects against neurodegeneration has been identified by University of Liverpool researchers. The finding enables novel treatments for human neurodegenerative diseases to be developed in the future.

With the predicted growth of the global ageing population, cases of age-associated neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS) are expected to rise. However, most current therapies do not decelerate or modify disease, and efforts to develop new treatments have been met with high attrition rates.

Amyotrophic Lateral Sclerosis (ALS)-Lou Gehrig's disease: Symptoms, Diagnosis, Treatment
Find out more about the degenerative disease- Amyotrophic lateral sclerosis.

‘The antiepileptic drug ethosuximide has been shown to protect against neurodegeneration in various nematode worm and rodent models.’

Tweet it Now

It is therefore a promising repurposing candidate for the treatment of multiple neurodegenerative diseases. However, high concentrations of the drug are required for its protective effects in animal models, which may limit its translational potential and impede the identification of its molecular mechanism of action.

100 times more potent

Researchers, led by Professor Alan Morgan from the University's Institute of Translational Medicine, aimed to develop a more potent version of the drug to avoid these impediments.

Caring for Alzheimers disease patients
Alzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The slide show will show how patients need support and care as dementia progresses.

In a collaborative approach involving University of Liverpool experts in Chemistry, (Professor Paul O'Neill, Dr Neil Berry), Nuclear magnetic resonance (Dr Marie Phelan) and nematode worms (Dr Shi Quan Wong, Professor Bob Burgoyne, Dr Jeff Barclay) the team identified a novel neuroprotective molecule called MPS that is chemically similar to ethosuximide, but is much more potent in reducing neurodegeneration in a worm model of ALS.

Professor Morgan, said: "Our research has revealed a novel neuroprotective activity of MPS that is over 100 times more potent than ethosuximide.

Quiz on Parkinson’s Disease
Parkinson's disease (PD) is a chronic and progressive nervous system disorder that results in a gradual loss of muscle control. It has an impact on the body's ability to control movement.

Source-Eurekalert

Mathematical Model Reveals Glycoside Mixes that Taste the Best
Stevia blends that deliver superior taste, allowing for unprecedented levels of sugar reduction while keeping taste quality has been identified by a research team at the Kellen Communications – New York.